Matches in SemOpenAlex for { <https://semopenalex.org/work/W4229457673> ?p ?o ?g. }
- W4229457673 abstract "Abstract Background Despite the known safety risks of long-term use of sedative-hypnotic/anxiolytic medications, there has been limited guidance for the safe and effective use of their chronic use in a primary care clinic setting. Understanding the characteristics of patients who receive sedative-hypnotic/anxiolytic medication and the clinical documentation process in primary care is the first step towards understanding the nature of the problem and will help inform future strategies for clinical research and practice. Objectives Characterize patients who received a sedative-hypnotic/anxiolytic prescription in primary care, and (2) gain an understanding of the clinical documentation of sedative-hypnotic/anxiolytic indication and monitoring in electronic medical records (EMR). Methods A random selection of patients who received a prescription for a benzodiazepine or Z-drug hypnotic between January 2014 and August 2016 from four primary care clinics in Winnipeg were included. Data was collected retrospectively using the EMR (Accuro®). Patient variables recorded included sex, age, comorbidities, medications, smoking status, and alcohol status. Treatment variables included drug type, indication, pattern of use, dose, adverse events, psychosocial intervention, tapering attempts, social support, life stressor, and monitoring parameters for sedative-hypnotic use. Demographic and clinical characteristics were described using descriptive statistics. Results Records from a sample of 200 primary care patients prescribed sedative-hypnotic/anxiolytics were analyzed (mean age 55.8 years old, 61.5% ≥ 65 years old, 61.0% female). Long-term chronic use (≥ 1 year) of a sedative-hypnotic/anxiolytic agent was observed in 29.5% of the sample. Zopiclone (30.7%) and lorazepam (28.7%) were the most common agents prescribed. Only 9.5% of patients had documentation of a past tapering attempt of their sedative-hypnotic/anxiolytic. The most common indications for sedative-hypnotic/anxiolytic use recorded were anxiety (33.0%) and sleep (18.0%), but indication was undetermined for 57.0% of patients. Depression (33.5%) and falls (18.5%) were reported by patients after the initiation of these agents. Conclusions A higher proportion of females and users 65 years and older received a prescription for a sedative-hypnotic/anxiolytic, consistent with previous studies on sedative-hypnotic use. We found inconsistencies in the documentation surrounding sedative-hypnotic/anxiolytic use. The indication for their use was unclear in a large number of patients. These findings will help us understand the state of the problem in primary care and inform future strategies for clinical research." @default.
- W4229457673 created "2022-05-11" @default.
- W4229457673 creator A5005321619 @default.
- W4229457673 creator A5008311242 @default.
- W4229457673 creator A5019605174 @default.
- W4229457673 creator A5046714945 @default.
- W4229457673 creator A5075034377 @default.
- W4229457673 creator A5080218303 @default.
- W4229457673 creator A5084403743 @default.
- W4229457673 creator A5091301253 @default.
- W4229457673 creator A5091664289 @default.
- W4229457673 date "2022-05-10" @default.
- W4229457673 modified "2023-10-14" @default.
- W4229457673 title "Insights into patient characteristics and documentation of the use of sedative-hypnotic/anxiolytics in primary care: a retrospective chart review study" @default.
- W4229457673 cites W139038528 @default.
- W4229457673 cites W1486315929 @default.
- W4229457673 cites W1529327349 @default.
- W4229457673 cites W1585855347 @default.
- W4229457673 cites W1837742065 @default.
- W4229457673 cites W1984191820 @default.
- W4229457673 cites W2007168079 @default.
- W4229457673 cites W2015804212 @default.
- W4229457673 cites W2017507208 @default.
- W4229457673 cites W2018685660 @default.
- W4229457673 cites W2023001725 @default.
- W4229457673 cites W2028756415 @default.
- W4229457673 cites W2031337382 @default.
- W4229457673 cites W2032405317 @default.
- W4229457673 cites W2034021789 @default.
- W4229457673 cites W2055166879 @default.
- W4229457673 cites W2079352942 @default.
- W4229457673 cites W2085842968 @default.
- W4229457673 cites W2100480708 @default.
- W4229457673 cites W2103482466 @default.
- W4229457673 cites W2131124552 @default.
- W4229457673 cites W2161393466 @default.
- W4229457673 cites W2163579301 @default.
- W4229457673 cites W2170043108 @default.
- W4229457673 cites W2287250061 @default.
- W4229457673 cites W2343853645 @default.
- W4229457673 cites W2344696711 @default.
- W4229457673 cites W2413457902 @default.
- W4229457673 cites W2578164715 @default.
- W4229457673 cites W2610505214 @default.
- W4229457673 cites W2868794329 @default.
- W4229457673 cites W2901519901 @default.
- W4229457673 cites W2905548507 @default.
- W4229457673 cites W2945365320 @default.
- W4229457673 cites W2977284957 @default.
- W4229457673 cites W3097705379 @default.
- W4229457673 doi "https://doi.org/10.1186/s12875-022-01724-9" @default.
- W4229457673 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35538427" @default.
- W4229457673 hasPublicationYear "2022" @default.
- W4229457673 type Work @default.
- W4229457673 citedByCount "0" @default.
- W4229457673 crossrefType "journal-article" @default.
- W4229457673 hasAuthorship W4229457673A5005321619 @default.
- W4229457673 hasAuthorship W4229457673A5008311242 @default.
- W4229457673 hasAuthorship W4229457673A5019605174 @default.
- W4229457673 hasAuthorship W4229457673A5046714945 @default.
- W4229457673 hasAuthorship W4229457673A5075034377 @default.
- W4229457673 hasAuthorship W4229457673A5080218303 @default.
- W4229457673 hasAuthorship W4229457673A5084403743 @default.
- W4229457673 hasAuthorship W4229457673A5091301253 @default.
- W4229457673 hasAuthorship W4229457673A5091664289 @default.
- W4229457673 hasBestOaLocation W42294576731 @default.
- W4229457673 hasConcept C118552586 @default.
- W4229457673 hasConcept C126322002 @default.
- W4229457673 hasConcept C195910791 @default.
- W4229457673 hasConcept C2426938 @default.
- W4229457673 hasConcept C2777602617 @default.
- W4229457673 hasConcept C2777765862 @default.
- W4229457673 hasConcept C2780930544 @default.
- W4229457673 hasConcept C2910067630 @default.
- W4229457673 hasConcept C558461103 @default.
- W4229457673 hasConcept C71924100 @default.
- W4229457673 hasConcept C98274493 @default.
- W4229457673 hasConceptScore W4229457673C118552586 @default.
- W4229457673 hasConceptScore W4229457673C126322002 @default.
- W4229457673 hasConceptScore W4229457673C195910791 @default.
- W4229457673 hasConceptScore W4229457673C2426938 @default.
- W4229457673 hasConceptScore W4229457673C2777602617 @default.
- W4229457673 hasConceptScore W4229457673C2777765862 @default.
- W4229457673 hasConceptScore W4229457673C2780930544 @default.
- W4229457673 hasConceptScore W4229457673C2910067630 @default.
- W4229457673 hasConceptScore W4229457673C558461103 @default.
- W4229457673 hasConceptScore W4229457673C71924100 @default.
- W4229457673 hasConceptScore W4229457673C98274493 @default.
- W4229457673 hasIssue "1" @default.
- W4229457673 hasLocation W42294576731 @default.
- W4229457673 hasLocation W42294576732 @default.
- W4229457673 hasLocation W42294576733 @default.
- W4229457673 hasLocation W42294576734 @default.
- W4229457673 hasOpenAccess W4229457673 @default.
- W4229457673 hasPrimaryLocation W42294576731 @default.
- W4229457673 hasRelatedWork W130997915 @default.
- W4229457673 hasRelatedWork W1557189296 @default.
- W4229457673 hasRelatedWork W2059591574 @default.
- W4229457673 hasRelatedWork W2157625204 @default.
- W4229457673 hasRelatedWork W2479156292 @default.